Open access peer-reviewed chapter

Exosomes: New Tuberculosis Biomarkers – Prospects From the Bench to the Clinic

By Nicole A. Kruh-Garcia, Jeff S. Schorey and Karen M. Dobos

Submitted: March 22nd 2011Reviewed: August 29th 2011Published: February 15th 2012

DOI: 10.5772/30720

Downloaded: 3675

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Nicole A. Kruh-Garcia, Jeff S. Schorey and Karen M. Dobos (February 15th 2012). Exosomes: New Tuberculosis Biomarkers – Prospects From the Bench to the Clinic, Understanding Tuberculosis Pere-Joan Cardona, IntechOpen, DOI: 10.5772/30720. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/understanding-tuberculosis-global-experiences-and-innovative-approaches-to-the-diagnosis/tuberculosis-biomarkers-prospects-from-the-bench-to-the-clinic" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

3675total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Molecular Techniques for Identification of Species of the Mycobacterium tuberculosis Complex: The use of Multiplex PCR and an Adapted HPLC Method for Identification of Mycobacterium bovis and Diagnosis of Bovine Tuberculosis

By Eduardo Eustáquio de Souza Figueiredo, Carlos Adam Conte Júnior, Leone Vinícius Furlanetto, Flávia Galindo Silvestre Silva, Rafael Silva Duarte, Joab Trajano Silva, Walter Lilenbaum and Vânia Margaret Flosi Paschoalin

Related Book

First chapter

Multi-Drug/Extensively Drug Resistant Tuberculosis (Mdr/Xdr-Tb): Renewed Global Battle Against Tuberculosis?

By Claude Kirimuhuzya

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us